摘要
目的:了解我院5年来临床分离的鲍曼不动杆菌构成及耐药变迁,为临床医师合理使用抗菌药物提供可靠依据。方法:回顾性分析2007年1月—2011年12月临床分离的鲍曼不动杆菌构成和耐药性。结果:5年来鲍曼不动杆菌分离率逐年上升,耐药率有逐年增高趋势,对头孢哌酮/舒巴坦的耐药率最低,其余已达72%以上。结论:鲍曼不动杆菌耐药十分严重,要加大监管力度,提高合理用药水平。
OBJECTIVE： To investigate the composition and drug resistance of acinetobacter baumannii in our hospital in the past 5 years so as to provide reliable references for clinicians in rational use of antibacterials. METHODS： The composition and drug resistance of acinetobacter baumannii in our hospital during 2007-2011 were analyzed retrospectively. RESULTS： The isolating rate of acinetobacter baumannii in our hospital increased year by year over the five years, with year-on-year increase in drug resistance rates. Acinetobacter baumannii had lowest resistance to cefoperazone/sulbactam, but its resistance rates to all the other antibiotics were as high as 72%. CONCLUSION： Aeinetobaeter baumannii are highly resistant to antibiotics, therefore, measures should be taken to tighten control on the use of antibiotics to improve the level of rational use of antibiotics.
出处
《中国医院用药评价与分析》
2012年第6期529-530,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
鲍曼不动杆菌
抗菌药物
耐药性
Aeinetobactor baumannii
Antibiotics
Drug resistance
